Cancer completely disappeared from two-thirds of 24 patients treated with a combination of the antibody petosemtamab and ...

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of ...

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment ...

The FDA has granted clearance to an investigational new drug application for CLD-201 for solid tumor treatment, based on ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients.

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

NSCLC, head and neck cancer, pancreatic cancer, and mesothelioma were enriched for TI-CH compared with other tumor types, the authors noted, while prostate, endometrial, ovarian, and small-cell ...

April is head and neck cancer awareness month, a time dedicated to raising awareness about a group of cancers that often go unnoticed until it's too late. These ...